Marinol (AbbVie Inc.)
Welcome to the PulseAid listing for the Marinol drug offered from AbbVie Inc.. This Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Dronabinol |
| SUBSTANCE NAME: | DRONABINOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-07-13 |
| END MARKETING DATE: | 0000-00-00 |
Marinol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Marinol from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 2.5(mg/1) |
| START MARKETING DATE: | 2010-07-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0051-0021_d2e02917-4a63-33d3-30f6-bcb9c2f35381 |
| PRODUCT NDC: | 0051-0021 |
| APPLICATION NUMBER: | NDA018651 |
Other DRONABINOL Pharmaceutical Manufacturers / Labelers:
